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Background: Despite the development of novel chemotherapy and biological agents, surgery is still an
importantoption forpatientswith pulmonarymetastases. Predictors of survival usually includedisease-free
interval, histologyof theprimary tumor, number ofmetastases and complete resection. The aimof this study
was to report the outcomes of patients with pulmonarymetastases from colorectal carcinoma submitted to
surgical resection, and to identify prognostic factors that signiﬁcantly affect overall survival.
Methods: We retrospectively analyzed 120 patients with previously treated colorectal carcinoma that had
developed pulmonary metastases, admitted between 1990 and 2006. Overall survival was estimated using
KaplaneMeier analysis. The log-rank and Breslow tests were used to compare survival differences for each
variable. Multivariate analyses to determine the independent prognostic factors for overall survival were
performed using the Cox proportional hazard model as identiﬁed by the univariate analyses.
Results: The median follow-up was 20.3 months (range: 3.27e134.2 months). The patients included in
this study underwent a total of 165 thoracotomies (mean of 1.37 thoracotomies/patient). The median
overall survival for all patients was 34.73 months, with an estimated 5-year survival rate of 24.39%.
Multivariate analyses identiﬁed unilateral lesions, neoadjuvant chemotherapy at lung resection and
complete resection as independent prognostic factors for overall survival.
Conclusions: These results indicate that prognostic factors identiﬁed in studies on pulmonary meta-
stasectomy for all primary tumors should be interpreted carefully for patients with possibility of pul-
monary metastasectomy from colorectal carcinoma.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
More than half of all patientswho undergo resection for colorectal
carcinoma are expected to have recurrence of their disease, and the
most frequent sites ofdistant recurrences are the liverand the lungs.1,2
Patients with untreated metastatic disease have a median survival of
less thanone-year andaﬁve-year survival of less than5%.3Despite the
development of novel chemotherapy and biological agents, surgery is
still an important option for patients with pulmonary metastases.
Although a large number of published series have reported the results
of surgical resectionof lungmetastases fromcolorectal carcinoma, the
effectivenessof suchapproachremainsunclearand reliablepredictors
of long-term survival are controversial.4
Predictors of survival usually include disease-free interval, histol-
ogy of the primary tumor, number of metastases and complete
resection. Among these, the most consistent predictor of survival is11, Sao Paulo (SP) 04120 080,
.
rao).
ciates Ltd. Published by Elsevier Ltcomplete resection.5,6 The number of metastatic nodules and their
impact on survival was initially considered to be an independent
predictor of survival.5 However, if complete resection can be achieved,
the number of pulmonary metastatic nodules does not seem to in-
ﬂuence survival.5,6
Since the early 1990s, our institution has employed a prospec-
tive protocol-oriented approach for the treatment of patients with
resectable lung metastases to deﬁne factors related to outcome
following lung metastasectomy. The aim of this study was to report
the outcomes of patients with pulmonary metastases from color-
ectal carcinoma submitted to surgical resection, and to identify
prognostic factors that signiﬁcantly affect overall survival (OS).
2. Material and methods
We retrospectively analyzed 120 patients with previously treated colorectal
carcinoma that had developed pulmonary metastases, admitted between 1990 and
2006. All patients were included and followed according to a prospective protocol.
This study was approved by the ethics review board at our institution.
Data were collected following a medical record review of each patient. The
following characteristics of the primary colorectal tumors were recorded: com-
pleteness of surgical resection, neoadjuvant and adjuvant treatment.d. All rights reserved.
Fig. 1. Overall survival after pulmonary metastasectomy for colorectal cancer.
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the primary colorectal carcinoma, followed by evaluations at routine follow-up
appointments. The disease free interval was deﬁned as the time period between
treatment of the primary tumor and the diagnosis of pulmonary metastases.
Patients with the following characteristics were considered eligible for pulmo-
nary resection: (1) controlled primary tumor, (2) nodules conﬁned to the lung pa-
renchyma without other sites of metastases, (3) nodules that were amenable to
surgical resection by computed tomography (CT), (4) pulmonary function and
clinical condition compatible with the scheduled operation, and (5) the unavail-
ability of more effective treatment options for the patient at that time.
All patients underwent a chest CT prior to surgery for assessment of resectability
of the nodules. Radiological characteristics were analyzed in each patient as follows:
the number of pulmonary nodules, the size of the largest nodule and the laterality of
the nodules. The number of nodules reported in this study was the ﬁnal number
conﬁrmed by the surgeon after complete resection.
A staged lateral thoracotomy was employed when bilateral nodules were dis-
covered at admission. This procedure was typically initiated on the side where
complete resection was deemed more difﬁcult and included the number and size of
the nodules identiﬁed by the chest CT scan, the anatomical position of one or more
nodules relative to the pulmonary hilum, and the potential need for a more complex
and extensive lung resection.
Patients underwent open surgery with general anesthesia and single lung
ventilation. A complete resection was attempted in all cases after palpation, while
preserving the lung parenchyma with a 10-mm margin. At our institution, media-
stinal lymph node dissection is not routinely performed in patients with lung me-
tastases. Wedge resection was used in peripheral nodules and lobectomy as well as
pneumonectomy in hilar nodules. In cases of a single pulmonary nodule at surgery,
frozen sections were collected. If the histological evidence suggested the possibility
of primary lung cancer with different histology of the nodule as compared to the
primary colorectal tumor, the patient was submitted to lobectomy with radical
mediastinal lymph node dissection whenever possible.
The date of surgery, type of resection (complete or incomplete), number of
malignant or benign nodules resected, size of the largest nodule resected, laterality
of the pulmonary nodules and type of lung resection (wedge, non-anatomic seg-
mentectomy, lobectomy or pneumonectomy) were documented.
Some patients received chemotherapy based on discretion of a medical oncol-
ogist, preceding surgical resection of the lung metastases. The type of radiological
response (partial, stable, complete, or progression) as deﬁned by RECIST12. These
both criteria were documented.
After surgery, the patientswere discharged from the hospital following chest tube
removal and in good clinical condition. After hospital discharge, the patients were
followed-up with clinical and radiological examinations (chest X-ray and CT scan)
every threemonths during theﬁrst twoyears andevery sixmonths subsequently until
the ﬁfth year. An annual radiological (chest X-ray) follow-upwas performed after ﬁve
years. The observed postoperative complications were fever >38 C, bleeding, air
leakage for more than seven days, intensive care unit stay for more than two days,
cardiac complications (arrhythmia, ischemia, and infarction), pulmonary atelectasis,
embolism or respiratory failure, stroke and infection. Recurrence was recorded when
new lesions were identiﬁed in the lung or elsewhere. Whenever necessary, a histo-
logical conﬁrmation of the new tumor was performed. If the recurrence was conﬁned
to the lungs and if the noduleswere considered resectable by the thoracic surgeon, the
patient was offered another attempt at complete disease resection.
3. Statistical analyses
The main outcome evaluated was death associated with the
tumor. Survival was calculated from the time of ﬁrst meta-
stasectomy to death or until the last follow-up. Overall survival was
estimated using KaplaneMeier analysis. The log-rank and Breslow
tests were used to compare survival differences for each variable.
Multivariate analyses to determine the independent prognostic
factors for overall survival were performed using the Cox propor-
tional hazard model as identiﬁed by the univariate analyses. Sur-
vival time was determined whenever more than one pulmonary
metastasectomy was performed, with time zero denoting the ﬁrst
thoracotomy. Statistical analyses were performed using SPSS 11.5
for Windows. Signiﬁcant differences were deﬁned as p <0.05.
4. Results
The patients included in this retrospective study (n ¼ 120) un-
derwent a total of 165 thoracotomies (mean of 1.37 thoracotomies/
patient); 388 nodules were resected, with a mean of 2.35 nodules
per thoracotomy and more than four nodules were resected in 20(24%) patients. The size of the nodules ranged between 1 and 6 cm,
where size of 368 nodules was up to 3 cm.We found 370 peripheral
nodules and 18 hilar nodules. All hilar nodules were treated
through lobectomy. All the other nodules were treated with wedge
resection and non-anatomic segmentectomy.
The median follow-up was 20.3 months (range: 3.27e134.2
months). Fifty-two (43.3%) patients were alive at the time of the
ﬁnal analyses, and 21 (17.5%) showed no evidence of disease.
Thirty-seven patients (30.8%) died due to metastatic colorectal
carcinoma, and two (1.6%) patients were considered lost to follow-
up after missing two medical evaluations.
The postoperative complication ratewas 4.16% (n¼ 5). Fever and
prolonged air leakage (>7 days) occurred in 3 patients, infection
and prolonged hospital stay (>30 days) occurred in 2 patients.
There was no 30-day mortality associated with the surgery used in
this series.
The median overall survival for all patients was 34.73 months,
with an estimated 5-year survival rate of 24.39% (Fig. 1). No sig-
niﬁcant difference in survival was detected between the groups
with respect to the number of thoracotomies (p ¼ 0.18).
Some factors evaluated in the univariate analyses, including
type of procedure and size of the largest nodule were not statisti-
cally signiﬁcant (p > 0.05). The patients’ characteristics and com-
plete univariate analyses are shown in Tables 1and 2. Multivariate
analyses identiﬁed laterality of the nodule including bilateral
involvement, chemotherapy prior to lung resection and complete
resection as independent prognostic factors for overall survival
(Figs. 2 and 3).5. Discussion
Improved survival following the resection of lung metastases
has increased the surgical indications for such lesions, thus con-
ﬁrming that surgery itself affects the outcomes of patients who are
candidates for a complete resection of nodules conﬁned to the
lungs. To date, several parameters, such disease-free interval,
number of lesions and completeness of resection and have been
reported as prognostic factors.5,7 In this study better OS was
observed for patients with unilateral metastatic disease that
received chemotherapy prior to lung resection and were submitted
to complete resection.
Many groups have investigated the difference between unilat-
eral and bilateral lesions in terms of survival.8 However, two articles
reported unilateral pulmonary metastases as a positive prognostic
factor for OS.9,10 According to our study, it is expected that patients
with bilateral metastases will gain less surgical beneﬁt even if all
Table 1
Univariate analysis and demographic data of the 120 patients submitted to pul-
monary metastasectomy.
Variables N Median
survival
(months)
p (Log Rank/
Breslow)
Age (years) 0.08/0.32
Less than 40 4 21.73
Between 40 and 65 58 29.16
>65 58 50.86
Gender 0.65/0.92
Female 43 39.53
Male 77 34.73
Chemotherapy preceding
resection of colorectal
tumor (neoadjuvant)
0.42/0.11
Yes 31 37.70
No 89 29.16
Chemotherapy following
resection of colorectal
tumor (adjuvant)
0.003/0.0012
Yes 78 22.23
No 42 39.86
Disease-free interval greater than 24 months 47 50.86 0.01/0.24
Disease-free interval less than 24 months 71 29.26
Number of nodules identiﬁed on CT scan 0.24/0.55
1 55 34.90
2 23 29.53
3 42 29.20
Laterality of the nodules 0.005/0.018
Unilateral 71 37.70
Bilateral 49 29.30
Chemotherapy preceding
lung resection
0.0001/0.0007
Yes 110 34.90
No 10 19.10
Objective tumor response to
neoadjuvant chemotherapy
prior to thoracotomy
0.0001/0.0007
Yes 110 34.90
No 10 19.10
Table 2
Univariate analysis and patients’ outcomes of the 120 patients submitted to pul-
monary metastasectomy.
Variables N Median
survival
(months)
p (Log Rank/
Breslow)
Complete resection 0.002/0.01
Yes 116 34.90
No 4 12.16
Type of procedure 0.44/0.27
Wedge/non-anatomic segmentectomy 98 32.66
Lobectomy 18 30.17
Exploratory thoracotomy 4 11.95
Number of nodules resected 0.73/0.76
1 24 29.16
2 50 34.90
3 46 39.50
Number of nodules
resected actually malignant
0.09/0.15
1 58 46.93
2 38 34.73
3 24 39.50
Size of the largest nodule (cm)
Less than 1 24 39.53 0.50/0.29
Between 1 and 3 74 29.53
>3 20 23.83
Number of thoracotomies
1 79 34.73 0.18/0.38
2 33 29.53
3 4 59.20
4 2 39.53
Last thoracotomy
resulted in complete
resection
0.002/0.10
Yes 114 34.73
No 6 12.16
Fig. 2. Overall survival after pulmonary metastasectomy for colorectal cancer ac-
cording to the chemotherapy prior to lung resection.
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of bilateral lesions might imply more tumor progression or devel-
opment than that of unilateral ones.9
Chemotherapy prior to lung resection was a positive prognostic
factor in our study. However, to the best of our knowledge, no study
reported this variable as a positive factor for OS.8,11e13 The use of
chemotherapy prior to lung resection has a number of potential
advantages in patients with pulmonary metastases. First, it helps
the selection of systemic agents and consequently provides in-
formation on tumor sensitivity. Another advantage is the possi-
bility of selecting candidates for resection by having a short
treatment interval. Moreover, determining the role of chemo-
therapy prior to lung resection for patients with pulmonary me-
tastases of colorectal origin can only be achieved through future
prospective studies.
Objective tumor response to neoadjuvant chemotherapy was
not tested before as prognostic factor and it was not a prognostic
factor in the present study. On the other hand, the literature reports
that evaluation of objective metastatic disease response could in-
ﬂuence the therapeutic decision and consequently, treatment re-
sults.14 Therefore, future studies could demonstrate that objective
tumor response to chemotherapy preceding pulmonary resection
inﬂuence the results of metastasectomy in colorectal cancer.
Nodules identiﬁed on CT scan were not a prognostic factor on
long-term survival. Some studies showed that the number of
nodules identiﬁed by CT is frequently used as a prognostic fac-
tor.15,16 However, the possibility of additional benign lesions found
during surgery is real. Chung et al. reported benign lesions in 20% ofsurgeries for resection of lung metastases.15 Possibly benign lesions
are responsible for different results about TC.
Microscopic complete surgical resection has been considered to
play an important role in the treatment of pulmonary metastases.17
Nonetheless, there have been reports in the literature about patients
whounderwent incomplete resection and the impact on survival was
not detected.18,19 It is possible that some patients may beneﬁt from
incomplete resection, because they have a lesser tumor burden left
behind. However, each one of these studies included small number of
patientswith incomplete resection (less than15%of the patients). Our
study reported a signiﬁcant improvement in long-term survival after
complete surgical resection. Melloni et al. in 2006 conﬁrmed the
importance of complete resection as a prognostic factor.7
Few studies in the last ten years analyzed patients with repeated
resection separately for ﬁve-year survival and none of them found
Fig. 3. Overall survival after pulmonary metastasectomy for colorectal cancer ac-
cording to complete resection.
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year survival reported by Saito et al. was 24.5% and the median
interval between the ﬁrst and second resection was 14 months.11
We did no ﬁnd repeat pulmonary resection as prognostic factor.
Despite the difference on the long-term survival, the statistical
signiﬁcant was not seen. Of all surgical procedures, the most
common thoracic procedure reported in the literature was seg-
mentectomy. Vogelsang et al. found that patients (n ¼ 52) under-
going segmentectomy seemed to have a better outcome than
patients (n ¼ 23) with anatomic lung resections.20 Literature did
not show other studies conﬁrming the report of Vogelsang et al.,
including our report. Maximum tumor size was analyzed in many
studies and was not a signiﬁcant prognostic factor in most studies.8
Younes et al. reported tumor size as a prognostic factor and
established a limit of three centimeters for impact on long-term
survival. However, this report included other malignances.21 Two
studies involving only patients with colorectal pulmonary metas-
tases found tumor size as a prognostic factor.20,22 We did not ﬁnd
tumor size to be a prognostic factor.
This article has some limitations. Unfortunately, PET-CT was not
available at our institution for most of the patients in this study. The
positron emission tomography using 18-Fluorodeoxyglucose (FDG
PET-CT) has proven to be of clinical value for the proper staging of
cancer patients to select better the candidates for resection. Ac-
cording to Pastorino et al., this method can eliminate 21% of pa-
tients who are otherwise considered to be surgery candidates.23
Another problem is that our study describes patients treated over
a long period of 17 years. The limitations presented above could
perhaps explain our low 5-years overall survival. Furthermore, the
following study did not examine some known prognostic factors
such as lymphadenectomy because our team does not utilize this
approach due to its controversial prognosis,10,24 as there are no
sufﬁcient data about the positive inﬂuence of lymph node
dissection.25
The current practice of pulmonary metastasectomy for color-
ectal carcinoma is well justiﬁed. Prognostic factors identiﬁed in
studies on pulmonary metastasectomy for all primary tumors
should be interpreted carefully for patients with possibility of
pulmonary metastasectomy from colorectal carcinoma. The role of
chemotherapy seems to be important and further studies may be
able to standardize the necessity and the best time to indicate
systemic treatment.
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